Medical News

RSS

New technique could eliminate hip replacement surgeries in young trauma patients

A novel surgery using transplanted bone and cartilage may help young patients avoid a hip replacement after a specific traumatic injury to the hip joint, according to a case study by orthopedic trauma specialists at Hospital for Special Surgery in New York. The study appears in the February issue of the Journal of Orthopaedic Trauma.

28 Jan 2010

ChemoCentryx announces the initiation of Phase I clinical trial of CCX168

ChemoCentryx, Inc., today announced the initiation of a Phase I clinical trial of CCX168, an orally-administered small molecule designed to treat autoimmune diseases.

28 Jan 2010

Lawmakers prod White House to release health reform deal documents

A group of Republicans and Rep. Henry Waxman, the California Democrat who chairs the Energy and Commerce committee, are prodding the White House to release documents detailing agreements cut with industry groups in exchange for their support for health reform, The Christian Science Monitor reports. "Those agreements - never released in any detail - set markers for Congress's work on healthcare, which many lawmakers felt bound to respect." Michael Burgess, R-Texas, one of the committee members seeking the documents, speculates, "Was this a payoff to the insurance industry?"

28 Jan 2010

Aubrey receives FDA clearance to market bioengineered wound dressings in U.S.

Aubrey Inc., an advanced wound care company, announced it has received clearance from the US Food and Drug Administration (FDA) to market the AWBAT Plus product line in the United States.

28 Jan 2010

Zelos Therapeutics commences dosing in clinical study of ZT-034 nasal spray for osteoporosis

Zelos Therapeutics, Inc. has initiated dosing in a seven day clinical study of a nasal spray formulation of ZT-034 (teriparatide) that is being developed in collaboration with development partner Aegis Therapeutics, LLC. Nasal spray ZT-034 is being developed as an alternative to Eli Lilly and Company’s Forteo (teriparatide [rDNA origin]) which generated approximately $800M in annual sales in 2009 for the treatment of osteoporosis and is administered by daily injection.

28 Jan 2010

Federal panel awards almost $500 million to La. to replace New Orleans Charity Hospital

Ending one of the longest-running disputes left by Hurricane Katrina, a federal arbitration panel ruled Wednesday that Louisiana would receive $474.8 million — nearly all it had requested — to pay for the replacement of Charity Hospital in New Orleans, which has been closed since the storm.

28 Jan 2010

Haitian President asks for better aid coordination, tents, jobs

Haitian President Rene Preval said the country is in need of sturdy tents and jobs to prevent an ongoing crisis, the Miami Herald reports. At a press conference, Preval said, "Help the people with tents. Create employment so people can buy food in the country. That is what's most important."

28 Jan 2010

Alcohol increases risk of violence in couples, says study

Alcohol increases the risk of violence in couples — especially violence both to and by the female partner. A new study of couples found that experienced intimate partner violence found 30.2 percent reported alcohol use before or during the event.

28 Jan 2010

Healthscreen Solutions announces fiscal year end 2009 financial results

Healthscreen Solutions Inc., Canada's premier provider of physician practice enhancement services and electronic medical record (EMR) software, today announced its record fiscal year end 2009 financial results.

28 Jan 2010

Innovative cardiac scanner allows early detection of heart conditions

The portable magnetometer is being developed at the University of Leeds, with funding from the Engineering and Physical Sciences Research Council (EPSRC) playing a key role.

28 Jan 2010

Ligand Pharmaceuticals acquires Metabasis Therapeutics

Ligand Pharmaceuticals Incorporated announced that it has completed the acquisition of Metabasis Therapeutics, Inc. (NASDAQ:MBRX), following approval of the transaction by Metabasis stockholders yesterday. As a result, Ligand gains a fully funded partnership with Roche, additional pipeline assets and drug discovery technologies and resources. The transaction was first announced on October 27, 2009.

28 Jan 2010

Texas Tribune: Will local docs overcome obstacles to go paperless?

American hospitals have lots of reasons to go digital, as well as a handful of motives to stick with paper.

28 Jan 2010

Novella Clinical and OSI Pharmaceuticals expand existing clinical service agreement

Novella Clinical Inc. (formerly PharmaLinkFHI) and OSI Pharmaceuticals, Inc. announced today that the Companies will expand their existing clinical service agreement. Under the terms of the new agreement, effective February 1, 2010, Novella will provide clinical research and related services to OSI for a period of two years as OSI transitions its clinical operations to its new Ardsley, New York campus. Novella will assume use of some of OSI’s facilities in Boulder and employ members of OSI’s Boulder staff.

28 Jan 2010

Oculus Innovative Sciences introduces Microcyn Solution for treatment of post-surgical wounds

Oculus Innovative Sciences, Inc., a commercial medical technology company that designs, produces and markets safe and effective tissue care products based upon the Microcyn® Technology platform, today unveiled Microcyn Solution with preservatives, at the New York Podiatric Clinical Conference & Exhibition being held in downtown Manhattan, January 29-31.

28 Jan 2010

NIDA supports Omeros' Addiction program

Omeros Corporation today announced that the National Institute on Drug Abuse (NIDA) is providing support for the Company's Addiction program. NIDA will fund substantially all of the costs of a Phase 2 clinical study to be conducted by New York State Psychiatric Institute researchers.

28 Jan 2010

Life Spine's DYNA-LINK Spinal System and PRESIDIO Spinal Plating System receive FDA marketing clearance

Life Spine announced today that the U.S. Food and Drug Administration (FDA) has given 510(k) marketing clearance to both the DYNA-LINK Spinal System and the PRESIDIO Spinal Plating System.

28 Jan 2010

Consumer survey results indicate cosmetic surgery is not taboo anymore

Cosmetic surgery is everywhere these days: TV, magazines, the Internet and more. And according to new data, society is indeed more comfortable talking about cosmetic surgery than ever before.

28 Jan 2010

EnteroMedics to submit an IDE application for next-generation Maestro RC System

EnteroMedics Inc., the developer of medical devices using neuroblocking technology to treat obesity and other gastrointestinal disorders, announced today that, following a recent meeting with the U.S. Food and Drug Administration (FDA) to discuss the Company’s EMPOWER™ study results and the regulatory process, the Company intends to submit an Investigational Device Exemption (IDE) application for a clinical trial to support a possible Premarket Approval (PMA) application for the next-generation Maestro® RC System in the treatment of morbid obesity.

28 Jan 2010

Excelsior Medical donates medical supplies to support Haiti earthquake relief effort

Excelsior Medical Corporation, one of the leading manufacturers of pre-filled catheter flush syringes, today announced that it is donating medical supplies to support the Haiti earthquake relief effort.

28 Jan 2010

Merck’s sales representatives ranked second by cardiologists

According to SDI’s recently released 2009 Ranking Tables Study, Merck’s sales representatives were ranked second by cardiologists, a noteworthy increase from sixth place in 2008. Pfizer was ranked first by cardiologists. Schering-Plough, AstraZeneca, and Novartis rounded out the top five, finishing third, fourth, and fifth, respectively.

28 Jan 2010